Use of a Ginkgo biloba extract for the treatment of mitochondrial disease of genetic origin
US8097287B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2007 |
| Grant date | Jan 17, 2012 |
| Priority date | — |
| Expiry date | Aug 31, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of Ginkgo biloba for the treatment of mitochondrial diseases of genetic origin and more particularly mitochondrial encephalomyopathies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.